- In July 2024, AIRS Medical successfully secured USD 20 million in a Series C funding round aimed at advancing the development of large language model (LLM)-driven companion robots designed to enhance mental well-being. This funding will facilitate the creation of innovative robotic solutions that leverage AI to support individuals in managing their mental health. The investment underscores a growing interest in integrating technology into mental health care, paving the way for improved therapeutic options
- In May 2024, AiM Medical Robotics formed a partnership with Brigham and Women’s Hospital to assess the capabilities of its robotic system for deep brain stimulation in patients suffering from Parkinson’s disease. This collaboration aims to explore the potential benefits of robotic-assisted interventions in enhancing treatment outcomes for individuals with this neurological condition. The agreement highlights the growing interest in integrating advanced robotics into clinical practice to improve patient care and therapeutic efficacy
- In February 2024, Medical Microinstruments successfully raised USD 110 million in a Series C funding round dedicated to the development of advanced microsurgical robots. This significant investment aims to enhance the precision and effectiveness of surgical procedures through innovative robotic technology. The funding reflects a strong commitment to advancing microsurgery and underscores the growing interest in integrating robotics into the medical field to improve patient outcomes
- In June 2023, Touchlab, a deep tech robotics company, unveiled a groundbreaking robot designed to enable doctors to remotely "feel" their patients during a trial at a hospital in Finland. The Välkky telerobot is operated by individuals wearing specialized gloves, utilizing advanced electronic skin technology to convey tactile sensations from its robotic hand to the users. During a three-month trial at Laakso Hospital in Helsinki, a trained team of nurses will assess the robot's effectiveness in enhancing patient care, reducing their workload, and minimizing the risk of transmitting infections or diseases
- In October 2021, Medtronic obtained CE mark approval for its Hugo robotic-assisted surgery (RAS) system, allowing the sale of this innovative technology across Europe. Earlier, in April 2021, Zimmer Biomet secured FDA clearance for its ROSA Partial Knee System, designed for robotically assisted partial knee replacement surgeries. These approvals reflect a growing recognition of robotic systems in enhancing surgical precision and patient outcomes in the evolving landscape of medical technology
Frequently Asked Questions
The major companies in the Medical Robots market include Intuitive Surgical (U.S.), Medtronic (Ireland), Stryker Corporation (U.S.), Zimmer Biomet (U.S.), Smith & Nephew (U.K.), Johnson & Johnson (U.S.), Siemens Healthineers (Germany), Accuray Incorporated (U.S.), Renishaw plc (U.K.), and Brainlab AG (Germany).
In October 2021, Medtronic obtained CE mark approval for its Hugo robotic-assisted surgery (RAS) system, allowing the sale of this innovative technology across Europe.
The countries covered in the Medical Robots market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.
